Renaissance Technologies’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $379K | Buy |
52,544
+12,968
| +33% | +$93.5K | ﹤0.01% | 2967 |
|
|
2025
Q1 | $327K | Buy |
39,576
+28,133
| +246% | +$232K | ﹤0.01% | 2901 |
|
|
2024
Q4 | $456K | Sell |
11,443
-2,000
| -15% | -$79.7K | ﹤0.01% | 2885 |
|
|
2024
Q3 | $116K | Sell |
13,443
-17,311
| -56% | -$150K | ﹤0.01% | 3232 |
|
|
2024
Q2 | $269K | Sell |
30,754
-1,576
| -5% | -$13.8K | ﹤0.01% | 2949 |
|
|
2024
Q1 | $792K | Buy |
32,330
+12,732
| +65% | +$312K | ﹤0.01% | 2632 |
|
|
2023
Q4 | $325K | Buy |
19,598
+6,744
| +52% | +$112K | ﹤0.01% | 2954 |
|
|
2023
Q3 | $240K | Sell |
12,854
-4,368
| -25% | -$81.6K | ﹤0.01% | 3026 |
|
|
2023
Q2 | $418K | Sell |
17,222
-892
| -5% | -$21.7K | ﹤0.01% | 2971 |
|
|
2023
Q1 | $396K | Sell |
18,114
-3,176
| -15% | -$69.4K | ﹤0.01% | 2995 |
|
|
2022
Q4 | $507K | Sell |
21,290
-7,934
| -27% | -$189K | ﹤0.01% | 2941 |
|
|
2022
Q3 | $804K | Sell |
29,224
-6,900
| -19% | -$190K | ﹤0.01% | 2630 |
|
|
2022
Q2 | $1.09M | Buy |
36,124
+21,631
| +149% | +$654K | ﹤0.01% | 2649 |
|
|
2022
Q1 | $779K | Buy |
14,493
+12,313
| +565% | +$662K | ﹤0.01% | 2887 |
|
|
2021
Q4 | $647K | Buy |
2,180
+52
| +2% | +$15.4K | ﹤0.01% | 2957 |
|
|
2021
Q3 | $825K | Buy |
+2,128
| New | +$825K | ﹤0.01% | 2654 |
|